D J Greenblatt

发表

A simplex procedure for fitting nonlinear pharmacokinetic models.

J S Harmatz, D J Greenblatt, D. Greenblatt, 1987, Computers in biology and medicine.

Kinetics and dynamics of lorazepam during and after continuous intravenous infusion

B L Ehrenberg, J S Harmatz, D J Greenblatt, 2000, Critical care medicine.

Pharmacokinetics and pharmacodynamics of oral diazepam: Effect of dose, plasma concentration, and time

C M Metzler, E J Antal, J S Harmatz, 1992, Clinical pharmacology and therapeutics.

Lorazepam: A Review of its Clinical

D J Greenblatt, D. Greenblatt, B Ameer, 1981, Drugs.

Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approaches.

J S Harmatz, D J Greenblatt, D. Greenblatt, 2000, Drug metabolism and disposition: the biological fate of chemicals.

Oxazepam kinetics: effects of age and sex.

J S Harmatz, D J Greenblatt, D. Greenblatt, 1980, The Journal of pharmacology and experimental therapeutics.

In Vitro Prediction of Clinical Drug Interactions With CYP3A Substrates: We Are Not There Yet

D J Greenblatt, D. Greenblatt, 2014, Clinical pharmacology and therapeutics.

Inhibition of cytochrome P450 by nefazodone in vitro: studies of dextromethorphan O- and N-demethylation.

J S Harmatz, D J Greenblatt, D. Greenblatt, 2003, British journal of clinical pharmacology.

Escitalopram (S-citalopram) and its metabolites in vitro: cytochromes mediating biotransformation, inhibitory effects, and comparison to R-citalopram.

J S Harmatz, D J Greenblatt, D. Greenblatt, 2001, Drug metabolism and disposition: the biological fate of chemicals.

Age, sex, and nitrazepam kinetics: Relation to antipyrine disposition

D R Abernethy, J S Harmatz, D J Greenblatt, 1985, Clinical pharmacology and therapeutics.

Falling off the straight line: some hazards of correlation and regression.

J S Harmatz, D J Greenblatt, 1992, Journal of clinical psychopharmacology.

Pharmacokinetics, central nervous system uptake, and lipid solubility of propranolol, acebutolol, and sotalol.

D R Abernethy, D J Greenblatt, D. Greenblatt, 1984, Cardiology.

Plasma concentrations and clinical effects after single oral doses of prazepam, clorazepate, and diazepam.

J S Harmatz, D J Greenblatt, D. Greenblatt, 1984, The Journal of clinical psychiatry.

Midazolam: Pharmacology and Uses

J G Reves, D J Greenblatt, D. Greenblatt, 1985, Anesthesiology.

Ibuprofen disposition in obese individuals.

D R Abernethy, D J Greenblatt, D. Greenblatt, 1985, Arthritis and rheumatism.

Interaction of caffeine with the GABAA receptor complex: alterations in receptor function but not ligand binding.

D J Greenblatt, G. Kaplan, D. Greenblatt, 1989, European journal of pharmacology.

Clinical Pharmacokinetics of Anxiolytics and Hypnotics in the Elderly

J S Harmatz, D J Greenblatt, D. Greenblatt, 2012, Clinical pharmacokinetics.

Pharmacokinetics and pharmacodynamics.

D J Greenblatt, D. Greenblatt, 1990, Hospital practice.

Caffeine‐induced behavioural stimulation is dose‐ and concentration‐dependent

D J Greenblatt, G. Kaplan, D. Greenblatt, 1990, British journal of pharmacology.

Clinical Pharmacokinetics of Anxiolytics and Hypnotics in the Elderly

J S Harmatz, D J Greenblatt, D. Greenblatt, 1991, Clinical pharmacokinetics.

Inhibition of desipramine hydroxylation in vitro by serotonin-reuptake-inhibitor antidepressants, and by quinidine and ketoconazole: a model system to predict drug interactions in vivo.

J S Harmatz, D J Greenblatt, D. Greenblatt, 1994, The Journal of pharmacology and experimental therapeutics.

Absolute and relative bioavailability of oral acetaminophen preparations.

D R Abernethy, D J Greenblatt, D. Greenblatt, 1983, Journal of pharmaceutical sciences.

Triazolam biotransformation by human liver microsomes in vitro: effects of metabolic inhibitors and clinical confirmation of a predicted interaction with ketoconazole.

J S Harmatz, D J Greenblatt, D. Greenblatt, 1996, The Journal of pharmacology and experimental therapeutics.

Appetite suppressant drugs as inhibitors of human cytochromes P450: in vitro inhibition of P450-2D6 by D- and L-fenfluramine, but not phentermine.

J S Harmatz, D J Greenblatt, D. Greenblatt, 1998, Journal of clinical psychopharmacology.

Pharmacology of benzodiazepine hypnotics.

D J Greenblatt, D. Greenblatt, 1992, The Journal of clinical psychiatry.

Unchanged cytochrome P450 3A (CYP3A) expression and metabolism of midazolam, triazolam, and dexamethasone in mdr(-/-) mouse liver microsomes.

D J Greenblatt, D. Greenblatt, M. Cotreau, 1999, Biochemical pharmacology.

Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam, and placebo

B L Ehrenberg, J S Harmatz, D J Greenblatt, 1989, Clinical pharmacology and therapy.

Diazepam disposition determinants

J S Harmatz, D J Greenblatt, D. Greenblatt, 1980, Clinical pharmacology and therapeutics.

Pharmacokinetic-Pharmacodynamic Relationships For Benzodiazepines

D J Greenblatt, D. Greenblatt, B. Laurijssens, 1996, Clinical pharmacokinetics.

Relationship of plasma and brain concentrations of caffeine and metabolites to benzodiazepine receptor binding and locomotor activity.

D J Greenblatt, G. Kaplan, D. Greenblatt, 1989, The Journal of pharmacology and experimental therapeutics.

Vancomycin therapy in patients with impaired renal function: a nomogram for dosage.

D J Greenblatt, D. Greenblatt, D. Krogstad, 1981, Annals of internal medicine.